← Leaderboards
Carlayne E Jackson
University Of Texas Hlth Sci Ctr San Ant
$996,667
Attributed
$996,667
Total exposure
15
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $99.7K · FY2005–08$100K$75K$50K$25K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$996,667 · 15
By mechanism
M01$996,667 · 15
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Lee McAlister-Henn$5,359,139
- Lawrence J Mandarino$19,789,957
- George I Henderson$8,047,111
- James D Lechleiter$14,710,925
- Rui J. Sousa$4,971,349
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationClinical ResearchHuman SubjectAmyotrophic Lateral SclerosisClinical TrialsOutcomes ResearchDrug Adverse EffectDrug Screening /EvaluationMuscle StrengthNeuromuscular Disorder ChemotherapyNutrition Related TagCreatineDietary SupplementsDiet TherapyMyositisInterferon AlphaLongitudinal Human StudyNervous System Disorder ChemotherapyDepressionFundingFunctional AbilityGrantInstitutionImmunotherapy
Grant awards (28)
EARLY TX OF ALS WITH NUTRITION AND NON-INVASIVE POSITIVE PRESSURE VENTILATION$1,215
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: CLINICAL TRIAL OF HIGH DOSE COQ10 IN ALS$868
M01 · FY2008 · RR · contact PI
EARLY TX OF ALS WITH NUTRITION AND NON-INVASIVE POSITIVE PRESSURE VENTILATION$29,923
M01 · FY2007 · RR · contact PI
CLINICAL TRIAL OF HIGH DOSE COQ10 IN ALS$3,325
M01 · FY2007 · RR · contact PI
MULTI-CENTER STUDY OF MINOCYCLINE IN ALS$30,328
M01 · FY2006 · RR · contact PI
CLINICAL TRIAL OF HIGH DOSE COQ10 IN ALS$15,610
M01 · FY2006 · RR · contact PI
A CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL IN MYASTHENIA GRAVIS$12,042
M01 · FY2006 · RR · contact PI
CLINICAL PILOT TRIAL OF CREATINE IN AMYOTROPHIC LATERAL SCLEROSIS (ALS)$11,596
M01 · FY2006 · RR · contact PI
EARLY TX OF ALS WITH NUTRITION AND NON-INVASIVE POSITIVE PRESSURE VENTILATION$3,568
M01 · FY2006 · RR · contact PI
A CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL IN MYASTHENIA GRAVIS$36,423
M01 · FY2005 · RR
CLINICAL PILOT TRIAL OF CREATINE IN AMYTROPHIC LATERAL SCLEROSIS (ALS)$35,465
M01 · FY2005 · RR
MULTI-CENTER STUDY OF MINOCYCLINE IN ALS$14,378
M01 · FY2005 · RR
CLINICAL TRIAL OF CELEBREX IN SUBJECTS WITH ALS$13,419
M01 · FY2005 · RR
Clinical Trial of Celebrex in Subjects with ALS$28,914
M01 · FY2004 · RR
Clinical Pilot Trial of Creatine in ALS$20,601
M01 · FY2004 · RR
Trial of Mycophenolate Mofetil in Myasthenia Gravis$18,072
M01 · FY2004 · RR
DOUBLE BLIND STUDY OF R MET HUBDNF GIVEN INTRATHECALLY TO SUBJECTS W/ALS$234,837
M01 · FY2002 · RR
DOUBLE BLIND STUDY OF R MET HUBDNF GIVEN INTRATHECALLY TO SUBJECTS W/ALS$234,837
M01 · FY2002 · RR
BETA INTERFERON ALPHA IN INCLUSION BODY MYOSITIS$0
M01 · FY2002 · RR
CLINICAL TRIAL OF CREATINE IN ALS$0
M01 · FY2002 · RR
CLINICAL TRIAL OF CREATINE IN ALS$0
M01 · FY2002 · RR
BETA INTERFERON ALPHA IN INCLUSION BODY MYOSITIS$0
M01 · FY2002 · RR
DOUBLE BLIND STUDY OF R MET HUBDNF GIVEN INTRATHECALLY TO SUBJECTS W/ALS$234,837
M01 · FY2001 · RR
BETA INTERFERON ALPHA IN INCLUSION BODY MYOSITIS$0
M01 · FY2001 · RR
CLINICAL TRIAL OF CREATINE IN ALS$0
M01 · FY2001 · RR
DOUBLE BLIND STUDY OF R MET HUBDNF GIVEN INTRATHECALLY TO SUBJECTS W/ALS$16,409
M01 · FY2000 · RR
BETA INTERFERON ALPHA IN INCLUSION BODY MYOSITIS$0
M01 · FY2000 · RR
CLINICAL TRIAL OF CREATINE IN ALS$0
M01 · FY2000 · RR